期刊文献+

人Nanog基因的克隆及其在COS-7L细胞中的表达 被引量:5

Cloning of human Nanog gene and its expression in COS-7L cells
下载PDF
导出
摘要 目的 :克隆人Nanog基因 ,构建其真核表达载体 ,并观察其在哺乳动物细胞COS 7L中的表达。方法 :利用HE2 93细胞的人基因组DNA为模板 ,以LA PCR技术 ,扩增Nango的基因 ,定向克隆到带Flag标签的pCMV载体中 ,测序后 ,挑选序列正确的真核表达质粒pFlag Nanog转染COS 7L细胞。用抗Flag标签的抗体 ,进行Westernblot和间接免疫荧光染色法检测Nango蛋白的表达。结果 :从人基因组DNA中克隆到序列正确的Nanog全长编码序列。所构建的Nanog质粒在COS 7L细胞中获得高效表达。结论 :人Nanog基因的克隆、真核表达载体的构建及在COS 7L中的表达均获得成功 ,为进一步研究其功能 ,尤其是探讨其在神经干细胞中的作用奠定了基础。 AIM: To clone human Nanog gene and express it in mammalian cells. METHODS: LA-PCR was used to amplify human Nanog gene from genomic DNA of HEK 293 cells. The Nanog gene was inserted into the Flag-tagged pCMV vector by gene recombination technique. After being confirmed by sequencing, the pFlag-Nanog was transfected into COS-7L cells. Western blot and indirect immunofluorescent staining against the Flag tag were used to detect the expression of Nanog protein. RESULTS: The sequence of the cloned Nanog was confirmed to be correct by sequence analysis. The COS-7L cells transfected with pFlag-Nanog could efficiently express Nanog protein. CONCLUSION: The cloning of human Nanog gene and the construction of its eukaryotic expression vector were successful. The study will lay the foundation for further research on the function of Nanog and its role in neural stem cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第4期495-498,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金项目资助 (No .30 2 4 0 0 1 2 ) NSFC/RGC联合科研基金项目资助 (No .30 2 1 80 0 3)
关键词 NANOG 克隆 分子 真核表达 human Nanog cloning, molecular eukaryotic expression
  • 相关文献

参考文献2

二级参考文献54

  • 1[38]Butteroni C, FM De, H Scholer, M Pesce. Phage display screening reveals an association between germline-specific transcription factor Oct4 and multiple cellular proteins. J Mol Biol 2000; 304:52940.
  • 2[39]Scholer H, T Ciesiolka, P Gruss. A nexus between Oct4 and EIA: implications for gene regulation in embryonic stem cells. Cell 1991; 66:291-304.
  • 3[40]Curatola AM, C Basilico. Expression of the K-fgf proto oncogene is controlled by 3' regulatory elemnents which are specific for embryonal carcinoma cells. Mol Cell Biol 1990; 10:2475-84.
  • 4[41]Yuan H, N Corbi, C Basilico, L Dailey. Developmentalspecific activity of the FGF4 enhancer requires the synergistic action of Sox-2 and Oct-3. Genes Dev 1995;9:263545.
  • 5[42]Ambrosetti DC, C Basilico, L Dailey. Synergistic activa tion of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 1997; 17:6321-9.
  • 6[43]Ambrosetti DC, HR Scholer, L Dailey, C Basilico. Modu lation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox-2 and Oct-3 on the fibroblast growth factor4 enhancer. J Biol Chem 2000; 275:23387-97.
  • 7[44]Tomioka M, M Nishimoto, S Miyagi, T Katayanagi, N Fukui, H Niwa, M Muramatsu, A Okuda. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 2002; 30:3202- 13.
  • 8[45]Nishimoto M, A Fukushima, A Okuda, M Muramatsu. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 1999; 19:5453-65.
  • 9[46]Wakayama T, R Yanagimachi. Cloning the laboratory mouse. Semin Cell Dev Biol 1999; 10:253-8.
  • 10[47]Wakayama T, H Tateno, P Mombaerts, R Yanagimachi. Nuclear transfer into mouse zygotes. Nat Genet 2000; 24:108-9.

共引文献57

同被引文献52

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部